BioMarin Pharmaceutical Inc. buy BMO Capital Markets
Start price
05.07.23
/
50%
€80.26
Target price
05.07.24
€93.60
Performance (%)
-6.16%
End price
06.07.24
€75.32
Summary
This prediction ended on 06.07.24 with a price of €75.32. With a performance of -6.16%, the BUY prediction by BMO_Capital_Markets finished with a loss. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.129% | -0.129% | -10.727% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by BMO_Capital_Markets for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $102.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten